✦ LIBER ✦

Sumatriptan, 5-HT1D receptors and obsessive-compulsive disorder

✍ Scribed by Lorrin M. Koran; Stefano Pallanti; Leonardo Quercioli

Book ID: 119575050
Publisher: Elsevier Science
Year: 2001
Tongue: English
Weight: 50 KB
Volume: 11
Category: Article
ISSN: 0924-977X
DOI: 10.1016/s0924-977x(01)00082-7

No coin nor oath required. For personal study only.

📜 SIMILAR VOLUMES

Sumatriptan (5-HT1D receptor agonist) do

Sumatriptan (5-HT1D receptor agonist) does not exacerbate symptoms in obsessive compulsive disorder

✍ Kamini L. Ho Pian; H. G. M. Westenberg; Harold J. G. M. van Megen; Johan A. den 📂 Article 📅 1998 🏛 Springer 🌐 English ⚖ 96 KB

P.3.015 Sumatriptan (5-HT1D receptor ago

P.3.015 Sumatriptan (5-HT1D receptor agonist) does not provoke symptoms in obsessive compulsive disorder

✍ K.L. Ho Pian; H.G.M. Westenberg; J.A. den Boer 📂 Article 📅 1997 🏛 Elsevier Science 🌐 English ⚖ 137 KB

Treatment of severe, drug resistant obse

Treatment of severe, drug resistant obsessive compulsive disorder with the 5HT1D agonist sumatriptan

✍ Liat Stern; Joseph Zohar; Rivka Cohen; Yehuda Sasson 📂 Article 📅 1998 🏛 Elsevier Science 🌐 English ⚖ 200 KB

5HT-2 receptor and fluvoxamine effect in

5HT-2 receptor and fluvoxamine effect in obsessive-compulsive disorder

✍ Stefano Erzegovesi; Paolo Ronchi; Enrico Smeraldi 📂 Article 📅 1992 🏛 John Wiley and Sons 🌐 English ⚖ 274 KB

The aim of the study was to test the role of the SHT-2 receptor in the antiobsessional effect of 5HT uptake inhibitors. For this purpose we designed a double blind controlled clinical trial, in which ritanserin (a specific 5HT-2 receptor antagonist) or placebo were administered to a sample of 10 pat

S.26.02 - Is 5HT5D involved in obsessive

S.26.02 - Is 5HT5D involved in obsessive compulsive disorder?

✍ J. Zohar 📂 Article 📅 1996 🏛 Elsevier Science 🌐 English ⚖ 323 KB

5 Obsessive-compulsive disorder

📂 Article 📅 2009 🏛 Reed Business 🌐 English ⚖ 66 KB